4.5 Review

Endocrine disorders in mitochondrial disease

Journal

MOLECULAR AND CELLULAR ENDOCRINOLOGY
Volume 379, Issue 1-2, Pages 2-11

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.mce.2013.06.004

Keywords

Mitochondrial disease; Endocrine; mtDNA; Diabetes; m.3243A > G

Funding

  1. Wellcome Trust [096919/Z/11/Z]
  2. UK NHS
  3. MRC [MR/K000608/1, G0700718] Funding Source: UKRI
  4. Medical Research Council [G0700718, MR/K000608/1] Funding Source: researchfish

Ask authors/readers for more resources

Endocrine dysfunction in mitochondrial disease is commonplace, but predominantly restricted to disease of the endocrine pancreas resulting in diabetes mellitus. Other endocrine manifestations occur, but are relatively rare by comparison. In mitochondrial disease, neuromuscular symptoms often dominate the clinical phenotype, but it is of paramount importance to appreciate the multi-system nature of the disease, of which endocrine dysfunction may be a part. The numerous phenotypes attributable to pathogenic mutations in both the mitochondrial (mtDNA) and nuclear DNA creates a complex and heterogeneous catalogue of disease which can be difficult to navigate for novices and experts alike. In this article we provide an overview of the endocrine disorders associated with mitochondrial disease, the way in which the underlying mitochondrial disorder influences the clinical presentation, and how these factors influence subsequent management. (C) 2013 The Authors. Published by Elsevier Ireland Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available